It is estimated that 1 in every 500 adults living in the U.S. have HCM, but a large percentage of patients are undiagnosed.  Listen to this podcast to gain insight into hypertrophic cardiomyopathy (HCM) screening and what it means to your patients.

Making the correct of hypertrophic cardiomyopathy (HCM) is critical in being able to initiate early surveillance and therapy to improve patient outcomes.  In this podcast focusing on pharmacologic treatment options, learn more about completed and ongoing myosin inhibitor clinical trials.

Accurate diagnosis of Hypertrophic Cardiomyopathy (HCM) is critical. HCM is a chronic and progressive disease putting patients at risk of serious complications and co-morbidities.  Early and correct detection may help reduce some of the consequences of HCM and improve outcomes. In this podcast, learn more about how to distinguish phenocopies from HCM.

Diagnosis of hypertrophic cardiomyopathy is typically done by echocardiogram to assess the thickness of the heart muscle and observe blood flow in and out of the heart. In this podcast, learn more about how echocardiography is used in the diagnosis, screening, and management of HCM.

Hypertrophic cardiomyopathy (HCM) is the most common form of inherited heart disease and can affect people of any age. In this episode, learn what causes hypertrophic cardiomyopathy in children and the clinical and genetic screening needed to diagnosis HCM.

Hypertrophic cardiomyopathy (HCM) is the most common form of genetic heart disease and can affect people of any age, yet it often goes undiagnosed. Genetic testing and counseling plays an important role in the diagnosis and management of HCM in patients in families. Learn more about genetic testing and counseling, and its impact on the patient’s family.

People with HCM are at increased risk for developing arrythmias such as atrial fibrillation, suffering from stroke and even sudden cardiac arrest. People with HCM face a risk of death more than 3 times greater than the average person of the same age without HCM. Learn more about the complex relation between atrial fibrillation and hypertrophic cardiomyopathy.

Surgical and interventional options such as surgical myectomy or alcohol septal ablation may help those with obstructive Hypertrophic Cardiomyopathy (HCM) to reduce or remove the obstruction. A similar option is unavailable to those with non-obstructive HCM.  Heart transplants are considered as a last resort for HCM patients who progress to end stages of the disease.  Learn more about advanced surgical approaches and emerging medical therapies for HCM.

The American Heart Association is committed to being your resource for diagnosing and treating patients with hypertrophic cardiomyopathy (HCM).  Listen today to Hypertrophic Cardiomyopathy: Diagnosis and Clinical Implications of Structural Phenotypes.

Invasive Strategies: Percutaneous and Surgical is a discussion on hypertrophic cardiomyopathy exploring invasive strategies for patients with HCM, including both percutaneous and surgical approaches.